| Literature DB >> 33892726 |
Paula Cristina Silva1, Omar Pereira de Almeida Neto2, Elmiro Santos Resende3.
Abstract
BACKGROUND: Heart failure (HF) is a severe and self-limiting syndrome. Its signs and symptoms are believed to predict poorer health-related quality of life scores, which are mainly influenced by deterioration in physical capacity. In the present study we try to analyze the influence of clinical and socioeconomic characteristics and physical capacity on the quality of life of people with HF diagnosis.Entities:
Keywords: Cardiorespiratory function; Heart Failure; Physical limitation; Quality of life
Mesh:
Year: 2021 PMID: 33892726 PMCID: PMC8063347 DOI: 10.1186/s12955-020-01634-3
Source DB: PubMed Journal: Health Qual Life Outcomes ISSN: 1477-7525 Impact factor: 3.186
Fig. 1Flowchart of the data collection procedure
Fig. 2Flowchart of the semi-annual evaluation process, from December 2015 to December 2017. T0 - Initial face-to-face evaluation; T1 - First telephone monitoring; T2 - Second face-to-face evaluation; T3 - Second telephone monitoring
Clinical characteristics of patients (n = 108) with heart failure seen at the cardiology outpatient clinic in T0
| VARIABLES | N | % | IC |
|---|---|---|---|
| I | 4 | 3,70 | 0,90-8,30 |
| II | 48 | 44,40 | 35,70-51,90 |
| III | 52 | 48,10 | 38,70-57,60 |
| IV | 4 | 3,70 | 0,90-8,30 |
| Chagasic Cardiopathy | 62 | 57,40 | 48,40-66,20 |
| Ischemic heart disease | 28 | 25,90 | 18,50-33,60 |
| Hypertensive Cardiopathy | 9 | 8,30 | 4,60-14,10 |
| Valvar Cardiopathy | 4 | 3,70 | 0,90-7,60 |
| Idiopathic | 5 | 4,60 | 0,70-8,30 |
| Systemic Hypertension | 91 | 84,30 | 78,50-90,30 |
| Arrhythmia | 43 | 39,80 | 30,60-47,20 |
| Coronary Arterial Disease | 32 | 29,60 | 23,10-41,00 |
| Dyslipidemia | 21 | 19,40 | 11,60-25,20 |
| Angina | 6 | 7,41 | 1,90-11,30 |
| Diabetes mellitus | 22 | 20,40 | 13,00-29,60 |
| Atrial Fibrillation | 18 | 16,70 | 9,30-24,30 |
| Obesity | 8 | 7,40 | 2,80-13,00 |
| Stroke | 6 | 5,60 | 0,90-10,20 |
| Beta-blocker | 93 | 86,10 | 78,70-92,60 |
| Diuretic | 81 | 75,00 | 64,60-82,40 |
| IECA / BRA | 71 | 65,70 | 57,00-75,40 |
| Aldosterone antagonist | 37 | 34,30 | 26,60-42,60 |
| Antithrombotic | 56 | 51,90 | 43,30-62,00 |
| Statin | 37 | 34,30 | 26,60-42,60 |
| Digital | 33 | 30,60 | 21,30-39,30 |
| Antidepressant / Anxiolytic | 19 | 17,60 | 10,00-25,20 |
| Nitrate | 9 | 8,30 | 4,20-15,00 |
| Pacemaker | 80 | 74,10 | 64,80-83,30 |
| Angioplasty | 10 | 9,30 | 3,50-14,80 |
| Revascularization | 5 | 4,60 | 1,90-9,50 |
| Valvoplasty | 2 | 1,90 | 0,03-4,60 |
| No surgical intervention | 11 | 10,18 | 4,30-13,84 |
| Smoking | 13 | 12,00 | 6,00-18,50 |
| Former smokers | 28 | 25,90 | 16,40-34,50 |
| Etilism | 10 | 9,30 | 4,60-15,30 |
| Ex-Etilists | 22 | 20,40 | 13,00-26,90 |
| Physical Activity | 5 | 4,60 | 0,90-8,30 |
| Cardiac Rehabilitation | 1 | 0,90 | 0,03-2,80 |
IC Confidence interval
Cardiopulmonary fitness of patients with heart failure seen in the outpatient clinic
| Times | Mín-Max | Median ± IQ | IC | |
|---|---|---|---|---|
| 1–8 | 3 ± 1 | 3–3 | < 0,001* | |
| 1–11 | 3 ± 3 | 3–4 | < 0,001* | |
| 1–7 | 3 ± 2 | 3–3 | < 0,001* | |
| 1–7 | 3 ± 3 | 2–3 | < 0,001* |
Min-Max Minimum-maximum, SD Standard deviation; p < 0.05; *: indicate data that do not have a symmetric distribution; IQ: interquartile amplitude; IC: confidence interval. T0 - Initial face-to-face evaluation; T1 - First telephone monitoring; T2 - Second face-to-face evaluation; T3 - Second telephone monitoring.
Quality of life related to the health of patients with heart failure seen in the outpatient clinic
| Times | Domains | Media ± DP | Median ± IQ | IC | |
|---|---|---|---|---|---|
| Physical | 25,50 ± 14 | 21,00-29,50 | |||
| Emotional | 10,44 ± 5,65 | 9,05-11,83 | 0,250 | ||
| Unspecific | 15,59 ± 4,44 | 14,50-16,68 | 0,153 | ||
| Total | 50,98 ± 15,52 | 47,17-54,80 | 0,186 | ||
| Physical | 24,59 ± 7,88 | 22,65-26,53 | 0,499 | ||
| Emotional | 9,74 ± 5,00 | 8,51-10,97 | 0,439 | ||
| Unspecific | 16,79 ± 5,00 | 15,56-18,02 | 0,181 | ||
| Total | 51,12 ± 15,73 | 47,25-54,99 | 0,449 | ||
| Physical | 25,80 ± 8,48 | 23,72-27,89 | 0,055 | ||
| Emotional | 10,50 ± 9 | 7,88-13,00 | |||
| Unspecific | 19 ± 6 | 18–20 | |||
| Total | 54,79 ± 15,64 | 50,94-58,63 | 0,183 | ||
| Physical | 28,64 ± 7,76 | 26,73-30,54 | 0,061 | ||
| Emotional | 11 ± 10 | 10–14 | |||
| Unspecific | 21,97 ± 5,09 | 20,72-23,22 | 0,731 | ||
| Total | 61,76 ± 19,95 | 57,59-65,92 | 0,281 |
SD Standard deviation; p < 0.05; *: indicate data that do not have a symmetric distribution; IQ Interquartile amplitude, IC Confidence interval.
Comparison of the evaluated constructs in patients with Cardiac Failure over the time of clinical follow-up (T0, T1, T2 and T3)
| Variable | Average + EP | Median - IQ (n) | Statistics ( |
|---|---|---|---|
| T1MINFIS | −0,29 ± 1,03 | −1 - 10,5 (75) | |
| T2MINFIS | 0,78 ± 1,13 | 1–10,25 (72) | |
| T3MINFIS | 4 ± 1,12 | 2–12,25 (68) | |
| T1MINEMO | −0,53 ± 0,72 | 0–7 (75) | |
| T2MINEMO | −0,21 ± 0,81 | 0–9,25 (72) | |
| T3MINEMO | 0,91 ± 0,92 | 1–10 (68) | |
| T1MININES | 0,99 ± 0,65 | 1–8 (75) | |
| T2MININES | 3,06 ± 0,56 | 3–7 (72) | |
| T3MININES | 6,56 ± 0,72 | 6–7,5 (68) | |
| T1MINTOTAL | 0,17 ± 1,76 | −0,5–19,5 (75) | |
| T2MINTOTAL | 3,63 ± 1,88 | 4–24,5 (72) | |
| T3MINTOTAL | 11,47 ± 2,29 | 10–24,75 (68) | |
| T1VSAQ | 0,08 ± 0,17 | 0–2 (75) | |
| T2VSAQ | −0,17 ± 0,16 | 0–2 (72) | |
| T3VSAQ | −0,25 ± 0,17 | 0–2 (68) |
MINFIS Physical domain, MINEMO Emotional domain, MININES Non-specific domain, MINTOTAL Total score, EP Standard error, IQ Interquartile range, n Number of participants, t Paired Student t test, Z Wilcoxon test, p Probability.
Correlation of socioeconomic, clinical and drug domains and the QL and cardiorespiratory fitness constructs of participants at T0
| VARIABLES | T0MINFIS | T0MINEMO | T0MININES | T0MINTOT | T0VSAQ |
|---|---|---|---|---|---|
| Age | −0,069 | 0,023 | −0,136 | − 0,055 | − 0,023 |
| Schooling | − 0,038 | − 0,176 | − 0,166 | 0,064 | |
| Civil Status | − 0,092 | − 0,042 | 0,013 | −0,089 | 0,015 |
| Indiv. Income (R$) | −0,134 | −0,05 | − 0,096 | −0,133 | 0,140 |
| Family Income (R$) | −0,037 | −0,186 | 0,046 | −0,071 | 0,147 |
| Diagnostic Tempo | − 0,028 | − 0,048 | − 0,215* | −0,092 | 0,067 |
| NYHA | 0,295 | −0,002 | 0,222* | 0,245* | −0,209* |
| LVEF | 0,035 | 0,115 | −0,139 | 0,011 | −0,023 |
| Beta-blockers | 0,049 | 0,034 | 0,106 | 0,067 | 0,037 |
| Antithrombotics | 0,133 | 0,156 | 0,124 | 0,160 | 0,209* |
| Diuretics | 0,113 | 0,024 | 0,169 | 0,098 | −0,068 |
| IECA/BRA | 0,004 | −0,034 | 0,114 | 0,010 | 0,092 |
| Ant. Aldosterone | −0,06 | −0,09 | 0,110 | 0,070 | 0,060 |
| Digitals | −0,021 | 0,036 | 0,021 | 0,041 | −0,080 |
| Nitrate | 0,023 | 0,034 | 0,036 | 0,056 | −0,023 |
| Statins | −0,078 | 0,032 | 0,047 | −0,021 | 0,047 |
| Antidep./Ansiol. | 0,095 | 0,151 | 0,104 | 0,149 | −0,213* |
MINFIS Physical domain, MINEMO Emotional domain, MININES Non-specific domain, MINTOTAL Total scan, VSAQ Veterans Specific Activity Questionnaire. *: p < 0.05; ┼: p < 0.01; t test of Student Paired.